Physician

Amit A Patel, MD

According to 2025 Medicare claims, Amit Patel, MD (NPI: 1306098827) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is TITAN HEALTH PARTNERS LLC (NPI: 1790396281; TIN: 852303328) and primary practice location at 07302-4397. Patel is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 162 traditional Medicare patients, billed 68,982 HCPCS/CPT codes, and received $997,081 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 765 prescription claims across 113 beneficiaries totaling $2,032,222 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 12 claims. Open Payments data shows 140 records totaling $163,613. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $554,080 to $997,081. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$505K$1.0M2015 Medicare payment: $554,080 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $658,923 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $583,364 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $889,165 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $976,838 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $710,744 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,010,026 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $746,436 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $722,148 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $997,081 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201526040,782$554,080
201622253,870$658,923
201720657,732$583,364
201823289,074$889,165
201924093,281$976,838
202016367,677$710,744
2021163107,407$1,010,026
202216185,282$746,436
202314779,490$722,148
202416268,982$997,081

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.2M$4.4M2015 Drug cost: $797,548 (USD; Tot_Drug_Cst)2016 Drug cost: $1,619,062 (USD; Tot_Drug_Cst)2017 Drug cost: $2,288,835 (USD; Tot_Drug_Cst)2018 Drug cost: $3,375,234 (USD; Tot_Drug_Cst)2019 Drug cost: $3,510,372 (USD; Tot_Drug_Cst)2020 Drug cost: $4,357,437 (USD; Tot_Drug_Cst)2021 Drug cost: $4,401,390 (USD; Tot_Drug_Cst)2022 Drug cost: $4,149,832 (USD; Tot_Drug_Cst)2023 Drug cost: $3,032,774 (USD; Tot_Drug_Cst)2024 Drug cost: $2,032,222 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201582742$797,548
2016971,180$1,619,062
20171081,293$2,288,835
20181561,608$3,375,234
20191471,493$3,510,372
20201601,778$4,357,437
20211531,825$4,401,390
20221481,631$4,149,832
20231281,241$3,032,774
2024113765$2,032,222

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$85$1692024 Medicare payment: $169 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R12$169

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more58120$156
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more124448$117
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's4481$15
36415Insertion of needle into vein for collection of blood sample112598$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count91427$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide11308$252,375
LenalidomideLenalidomide11308$170,517
TecentriqAtezolizumab13273$140,495
ProcritEpoetin Alfa401,148$123,662
ZirabevBevacizumab-Bvzr15329$103,578

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
K0001Standard wheelchairYN/R12$169

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.140$163,613Daiichi Sankyo Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amit A. Patel, MD?

Tedicare shows public-source Medicare data for Amit A. Patel, MD (NPI 1306098827), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amit A. Patel, MD have ACO affiliation data?

Amit A. Patel, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Amit A. Patel, MD?

Amit A. Patel, MD is linked to TITAN HEALTH PARTNERS LLC (billing NPI 1790396281) in the available physician profile data.

Does Amit A. Patel, MD have Open Payments data?

Amit A. Patel, MD has 140 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.